Wenhong Xu
-
- Cardiovascular Function and Risk Factors 6
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 4
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 8
- Molecular Biology top 10%
- Mitochondrial Function and Pathology 5
- Metabolomics and Mass Spectrometry Studies 4
-
- Nanoplatforms for cancer theranostics 7
-
- Fatty Acid Research and Health 6
-
- Cancer Cells and Metastasis 4
- Co-authors
- Todd McDonaldAgnieszka SidorYongge LiuJennifer E. Van EykBrian O’RourkeSheng WangWilliam C. StanleyMin Han
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wenhong Xu
50 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 111
- Pathology and Forensic Medicine 293
- Cardiology and Cardiovascular Medicine 358
- Biochemistry 109
- Biomaterials 188
- Molecular Biology 970
Countries citing papers authored by Wenhong Xu
This map shows the geographic impact of Wenhong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhong Xu more than expected).
Fields of papers citing papers by Wenhong Xu
This network shows the impact of papers produced by Wenhong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhong Xu. The network helps show where Wenhong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenhong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2020 | 4 | |
| 3 | 2019 | 32 | |
| 4 | 2019 | 2 | |
| 5 | 2019 | 60 | |
| 6 | 2019 | 46 | |
| 7 | 2018 | 55 | |
| 8 | 2016 | 6 | |
| 9 | 2016 | 25 | |
| 10 | 2015 | 16 | |
| 11 | 2014 | 26 | |
| 12 | 2014 | 35 | |
| 13 | 2013 | 7 | |
| 14 | 2012 | 33 | |
| 15 | 2009 | 38 | |
| 16 | 2009 | 81 | |
| 17 | 2008 | 46 | |
| 18 | 2008 | 146 | |
| 19 | 2006 | 19 | |
| 20 | [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis]. | 2006 | 2 |
About Wenhong Xu
Wenhong Xu is a scholar working on Biomaterials, Cancer Research and Biochemistry, having authored 54 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (7 papers), Cardiovascular Function and Risk Factors (6 papers), Fatty Acid Research and Health (6 papers), Mitochondrial Function and Pathology (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (293 citations), Cardiology and Cardiovascular Medicine (358 citations) and Biochemistry (109 citations). Wenhong Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Todd McDonald, Agnieszka Sidor, Yongge Liu, Jennifer E. Van Eyk, Brian O’Rourke, Sheng Wang, William C. Stanley, Min Han, Ramzi J. Khairallah and Karen M. O’Shea. Their work appears in journals such as Science, PLoS ONE and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.